News from phosphagenics limited

( Australia:POH,OTC-PINK:PPGNY,OTC-BB:PPGNY,OTC-BB:PPGNY.OB,OTC-QX:PPGNY.QX,OTC-QX:PPGNY)

Jul 21, 2014, 07:00 ET

Phosphagenics Completes First Tranche of A$19.3 Million Capital Raising

Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$12.2 million of its A$16.3...

Jul 11, 2014, 09:30 ET

Phosphagenics' A$19.3 million Capital Raising

 Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$19.3 million via a...

May 21, 2014, 07:00 ET

Phosphagenics' Topical Oxycodone Patch Alleviates Pain in Racehorses

A Phosphagenics Limited (ASX:POH, OTCQX: PPGNY) study using its TPM®/Oxycodone topical patch to manage shin soreness pain for thoroughbred...

Mar 26, 2014, 08:00 ET

Phosphagenics to Host Investor Call on Wednesday, April 2nd at 4:00pm EDT (USA)

Phosphagenics Limited (ASX: POH) (OTCQX: PPGNY) ("Phosphagenics" or "the Company") announced today that management will host an investor...

Oct 24, 2013, 08:00 ET

Phosphagenics' Oxymorphone Patch Success

  - Oxymorphone patch achieves world first therapeutic plasma concentrations in all subjects in clinical trial - Results from...

May 21, 2013, 00:17 ET

Phosphagenics Signs Research Agreement with the Agricultural Research Service

- Collaboration with the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) in treatment of mastitis -...

May 29, 2009, 09:26 ET

Phosphagenics Announces Completion of Transdermal Patch Prototypes

- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of...

Dec 08, 2008, 09:33 ET

Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine

Trial Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical Anaesthetic Xylocaine(R) Phosphagenics Limited...

Nov 12, 2008, 08:00 ET

Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans

Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) announced today that it has initiated a phase 1 human clinical trial using its...

Mar 19, 2008, 01:00 ET

Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes

MELBOURNE, Australia, March 19 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that it has...

Mar 18, 2008, 01:00 ET

GRAS Status Opens Door to U.S. Food Industry

MELBOURNE, Australia, March 18 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today...

Feb 19, 2008, 00:00 ET

Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid

MELBOURNE, Australia, Feb. 19 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) today...

Feb 11, 2008, 00:00 ET

Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial

MELBOURNE, Australia, Feb. 11 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) and Nestle...

Jan 30, 2008, 00:00 ET

Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination

MELBOURNE, Australia, Jan. 30 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today...

Dec 17, 2007, 00:00 ET

Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results

MELBOURNE, Australia, Dec. 17 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today...

Oct 04, 2007, 01:00 ET

Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial

MELBOURNE, Australia, Oct. 4 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) and Nestle Nutrition (Nestle)...

Sep 17, 2007, 01:00 ET

Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial

MELBOURNE, Australia, Sept. 17 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that,...

Aug 08, 2007, 01:00 ET

Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results

MELBOURNE, Australia, Aug. 8 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today...

Jul 10, 2007, 01:00 ET

Phosphagenics and Nestle Nutrition Extend Option Agreement

MELBOURNE, Australia, July 10 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) today...

Jul 09, 2007, 01:00 ET

Phosphagenics Lists on the International OTCQX Market in the U.S.

MELBOURNE, Australia, July 9 /PRNewswire-FirstCall/ -- Phosphagenics Limited (ASX: POH; AIM: PSG; OTCQX: PPGNY) today announced that its Level 1...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge